Semrush, performance.io Research Finds Gap Between Pharma Search Rankings and AI Citations

New research suggests organic rankings remain closely linked to Google AI Overview citations, although pharma brands receive a smaller share of citations.

solli
18th November 2026

New research from Semrush and specialist pharma agency performance.io has examined how pharmaceutical brands appear in Google’s AI Overviews. 

The study found that 83.8% of AI Overview citations across the pharma-related searches analysed came from domains ranking in the top 10 organic search results. Domains ranking No. 1 were cited 68.8% of the time. 

However, pharma brand websites accounted for 9.2% of No. 1 organic rankings but received just 4.2% of AI Overview citations, highlighting a gap between traditional search visibility and inclusion in AI-generated answers. 

The research also found that AI Overviews appeared above other search results features 98.6% of the time when present. 

Previewed at Semrush Spotlight 2026, the study analysed more than 14,300 keywords and 689,100 keyword snapshots across five therapeutic areas, including Alzheimer’s disease, type 2 diabetes and plaque psoriasis. 

According to the companies, the findings reinforce the importance of traditional SEO while suggesting that marketers should also consider AI citations when evaluating search visibility. 

The research focused on US desktop searches, with AI Overview analysis covering September 2024 to July 2026. It did not measure clicks or user behaviour. 

solli’s Final Thoughts 

The findings highlight a distinction for pharma marketers: ranking highly in organic search does not necessarily mean appearing in AI-generated answers. 

As AI search develops, monitoring citations alongside traditional SEO metrics may help brands better understand how their content is being surfaced to patients and HCPs. 

Read the full news piece HERE

Most Popular Content